Sign In
Buy CARA
$5.32
+0 (+0%)
At Close: Jul 14, 2025
Cara Therapeutics Inc (CARA) Q2 2020 Earnings Call Transcript
09:30pm, Tuesday, 11'th Aug 2020
This is Jack Hildick-Smith with Stern Investor Relations, and welcome to Cara Therapeutics Second Quarter 2020 Financial Results and Update Conference Call. Before we begin, let me remind you that st
Cara Therapeutics (CARA) Reports Q2 Loss, Tops Revenue Estimates
10:05pm, Monday, 10'th Aug 2020
Cara (CARA) delivered earnings and revenue surprises of 20.59% and 2.90%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Cara Therapeutics Reports Second Quarter 2020 Financial Results
08:01pm, Monday, 10'th Aug 2020
– Conference call today at 4:30 p.m. ET – STAMFORD, Conn., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commerci
The Week Ahead In Biotech: Bausch Health, Fennec Pharma FDA Decisions And Smid-cap Earnings
12:00am, Sunday, 09'th Aug 2020
Biotech stocks advanced in the week ended Aug. 7, buoyed by multiple catalysts. Aside from the broader market strength, mostly positive earnings and continuing coronavirus...
Cara Therapeutics to Present at the Canaccord Genuity 40th Annual Growth Conference
08:01pm, Thursday, 06'th Aug 2020
STAMFORD, Conn., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alle
Vifor Pharma Group Reports Continued Growth in H1 2020
12:00am, Thursday, 06'th Aug 2020
Regulatory News: Vifor Pharma Group reported growth in H1 2020, despite challenges to patient access conditions caused by the COVID-19 pandemic. The f
Cara Therapeutics to Announce Second Quarter 2020 Financial Results on August 10, 2020
08:01pm, Monday, 03'rd Aug 2020
STAMFORD, Conn., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to allevi
Analysts Estimate Cara Therapeutics (CARA) to Report a Decline in Earnings: What to Look Out for
04:33pm, Wednesday, 29'th Jul 2020
Cara (CARA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cara Therapeutics (NASDAQ:CARA) Upgraded to Hold by Zacks Investment Research
06:24am, Wednesday, 22'nd Jul 2020
Zacks Investment Research upgraded shares of Cara Therapeutics (NASDAQ:CARA) from a sell rating to a hold rating in a research report sent to investors on Tuesday morning, Zacks.com reports. According
Zacks Investment Research Lowers Cara Therapeutics (NASDAQ:CARA) to Sell
10:26pm, Wednesday, 15'th Jul 2020
Zacks Investment Research lowered shares of Cara Therapeutics (NASDAQ:CARA) from a hold rating to a sell rating in a research report report published on Tuesday, Zacks.com reports. According to Zacks,
Cara Therapeutics Inc (NASDAQ:CARA) Shares Bought by Wells Fargo & Company MN
05:38am, Tuesday, 14'th Jul 2020
Wells Fargo & Company MN lifted its stake in shares of Cara Therapeutics Inc (NASDAQ:CARA) by 2.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Co
Cara Therapeutics'(NASDAQ:CARA) Share Price Is Down 31% Over The Past Year.
06:47pm, Monday, 13'th Jul 2020
While not a mind-blowing move, it is good to see that the Cara Therapeutics, Inc. (NASDAQ:CARA) share price has gained...
Is Cara Therapeutics Inc (CARA) A Good Stock To Buy?
05:34pm, Wednesday, 08'th Jul 2020
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming). In these volatile market
Geode Capital Management LLC Acquires 67,954 Shares of Cara Therapeutics Inc (NASDAQ:CARA)
07:58am, Sunday, 05'th Jul 2020
Geode Capital Management LLC lifted its holdings in Cara Therapeutics Inc (NASDAQ:CARA) by 12.6% during the first quarter, according to the company in its most recent 13F filing with the Securities &
